| INTRODUCTION
Borrelia burgdorferi, the primary causative agent of Lyme disease in the United States, is transmitted via tick bite and is known to disseminate into host tissues where it can survive for the lifetime of the host. If left untreated, the human infection can become chronic leading to a number of different symptoms that vary in part with the infecting strain and species of Lyme disease Borrelia. Human infection with B. garinii strains, which occur with greater frequency than B. burgdorferi in parts of Europe and Asia, more commonly present with neurologic symptoms (Centers for Disease Control and Prevention, 2015) , whereas infection with B. burgdorferi commonly presents with monoarticular arthritis (Baranton et al., 1992; Strle, Ružić-Sabljić, Cimperman, Lotrič-Furlan, & Maraspin, 2006; van Dam et al., 1993) .
Lyme disease Borrelia spp. exist in a tick-vertebrate life cycle in which the bacteria are exposed to immune defences of both the host and the tick. The spirochetes are able to evade clearance by these systems and can survive and cause a disseminated infection in the mammalian host, in part by modulation of their surface proteome.
For example, when entering the tick midgut, the bacteria upregulate the production of the outer surface protein A (OspA), which is promptly downregulated when the tick takes a blood meal from the next host (Schwan, Piesman, Golde, Dolan, & Rosa, 1995) . Exposure to blood products inside the tick upregulates the production of outer surface protein C (OspC), presumably to prepare the bacteria for entry into the host tissues via tick bite (Srivastava & de Silva, 2008) .
Disseminated infection by Lyme disease Borrelia involves bacteremia and spread to distant tissues, and these bacteria have evolved mechanisms to evade clearance by the complement cascade present in the host blood and tissues (Alitalo et al., 2002; Brangulis, Petrovskis, Kazaks, Akopjana, & Tars, 2014; Caesar, Johnson, Kraiczy, & Lea, 2013; Hallström et al., 2013; Hammerschmidt et al., 2012; Hammerschmidt et al., 2014; Kenedy, Vuppala, Siegel, Kraiczy, & Akins, 2009; Kraiczy et al., 2004) . The complement cascade involves a series of proteolytic cleavage events of inactive precursors into active enzymes in the host serum and tissues that result in the formation a lytic pore complex in the pathogen membrane called the membrane attack complex ( Figure   S1 ). The complement cascade can be activated by the classical, lectin, or alternative pathways. The classical and lectin pathways are triggered by recognition of the pathogen surface by antibodies or mannosebinding lectin, respectively, whereas the alternative pathway is activated by spontaneous deposition of the complement component, C3, onto the surface of the bacteria. The host possesses many mechanisms to regulate the activation of the complement cascade to minimise harm to host tissues. Proteins such as Factor H and Factor H-like protein 1 inhibit the alternative complement cascade, whereas proteins such as C4 binding protein (C4BP) and C1 inhibitor (C1-INH) function to inhibit the classical and lectin pathways (Ratnoff, Pensky, Ogston, & Naff, 1969 ; reviewed in Meri & Jarva, 1998 ; see Figure S1 ). The host also produces proteins, such as vitronectin, CD59, and clusterin, that inhibit the end stages of the complement cascade common to all branches.
B. burgdorferi is able to recruit many of these host factors to its surface creating a cloak of protection from the activities of the complement cascade. Production of cold shock protein A (CspA; Hallström et al., 2013; Hammerschmidt et al., 2014; Kenedy et al., 2009) or cold shock protein Z (CspZ; Hartmann et al., 2006; Siegel et al., 2008) , have been shown to recruit Factor H and Factor H-like 1 to the spirochete surface, in vitro, and ultimately inhibit the alternative complement cascade. Recently, it was shown that the fibronectin and glycosaminoglycan binding protein, BBK32, is able to bind to the complement component C1 cleavage product, C1r, and inhibit its activation (Garcia, Zhi, Wager, Höök, & Skare, 2016) . This binding activity on the surface of B. burgdorferi was found to inhibit in vitro complement activation through the classical pathway, in vitro (Garcia et al., 2016) . Interestingly, two studies of mice deficient in complement component C3 suggested that complement-mediated defence diminishes the bacterial burden in a variety of tissues, particularly at 2 weeks after infection (Lawrenz et al., 2003) . Nevertheless, other studies describe a relatively similar course of infection in mice deficient in complement components C5 compared to wild-type (WT) mice, suggesting that B. burgdorferi may encode complement inhibition mechanisms that limit the effectiveness of complement defences at multiple steps in vivo (Bockenstedt, Barthold, Deponte, Marcantonio, & Kantor, 1993) .
OspC is a 22 kDa, dimeric lipoprotein on the surface of Lyme disease Borrelia. Production of OspC, induced in the midgut of a feeding tick, has been shown to be critical for the early stages of mammalian infection (Grimm et al., 2004; Tilly et al., 2006) . The high immunogenicity and virulence attributes of OspC have made the protein a focus of vaccination studies for several years with a moderate amount of success (Gilmore, Kappel, Dolan, Burkot, & Johnson, 1996; Preac-Mursic et al., 1992; Probert & LeFebvre, 1994; Wilske et al., 1993) . OspC displays high variability of the central region of the OspC protein among not only different species of Lyme disease Borrelia but also between different strains within the same species (Lin, Oliver, & Gao, 2002) , limiting the cross-protective activity of vaccines based on OspC (Probert, Crawford, Cadiz, & LeFebvre, 1997 Seinost et al., 1999) . Strains that produce class A, B, C, D, I, K, or N have been associated with disseminated infection in humans or mice (Earnhart et al., 2005; Lagal, Postic, Ruzic-Sabljic, & Baranton, 2003; Seinost et al., 1999; Wang et al., 2001; Wang et al., 2002) . Due to the differences in invasiveness and disease seen with Borrelia carrying the various OspC classes, and its requirement for B. burgdorferi survival early in infection, it is possible that OspC may be an effector for evasion of innate defences in the host.
By observing the survival capabilities in vivo of ospC deletion and complemented derivatives of B. burgdorferi in mouse models of Lyme borreliosis, we identified a novel role for OspC in bloodstream survival.
By utilising ospC mutant B. burgdorferi strains producing different classes of OspC protein from two well studied strains of B. burgdorferi, strain B31-A3 (class A) and strain N40 clone D10/E9 (class M), as well as from B. garinii strain PBr (class B), we showed a similarity in afforded bloodstream survival of the bacteria. Through a series of in vitro assays, we identified a potential mechanism for the action of the OspC protein from B. burgdorferi but not B. garinii in affording Borrelia resistance to the classical and/or mannose-binding lectin branches of the complement cascade, promoting bloodstream survival of the bacteria.
2 | RESULTS 2.1 | An OspC-deficient mutant B. burgdorferi exhibits reduced survival in the blood at 30 min post inoculation
We previously showed that 60 min after intravenous inoculation into C3H/HeN mice, the OspC-deficient B. burgdorferi strain B31-A3ΔospC was undetectable in the blood compared to WT infectious B. burgdorferi strain B31-A3 (Caine & Coburn, 2015) . To characterise the kinetics of clearance of the ospC mutant from the bloodstream of mice, C3H/HeN mice were intravenous inoculated with infectious B. burgdorferi strain B31-A3 or an isogenic ospC mutant (Table S1) Table S2 ). At 10 min post inoculation, 3/ 8 mice infected with the ospC mutant had cleared spirochetes from their blood compared to 1/6 mice infected with WT bacteria (Figure 1 and Table S2 ). By 20 min post inoculation, 6/8 mice had cleared the ospC mutant bacteria compared to 2/6 mice infected with WT bacteria (Figure 1 and Table S2 ). By 30 min, all but one mouse had cleared the ospC mutant bacteria compared to 1/6 of the mice infected with WT bacteria (Figure 1 and Table S2 ). This result is seen again at 60 min post inoculation where, in these experiments, 2/6 WT-inoculated mice had cleared bacteria from their blood compared to 6/8 of mice inoculated with the ospC mutant ( Figure 1 and Table S2 ). For each time point, the number of bacteria detected was not statistically significantly different between WT and ospC mutant inoculated mice. However, the number of mice that had cleared WT or ospC mutant bacteria at 30 min post inoculation was significantly different by Fisher's exact test (Table S2) . From these data, we concluded that the ospC mutant bacteria begin to be cleared from the bloodstream of a mouse within the first 20-30 min post inoculation compared to WT bacteria that are able to survive throughout the duration of the experiment.
| OspC from B. burgdorferi and B. garinii promotes bloodstream survival in vivo
Different species of Lyme disease Borrelia show varying sensitivity to human serum proteins (van Dam et al., 1997) . B. burgdorferi is known to be resistant to killing by human serum in vitro, whereas the B. garinii strains tested are more sensitive (Kurtenbach et al., 2002; van Dam et al., 1993; van Dam et al., 1997) . At the indicated times post inoculation, blood was collected from the saphenous vein, and bacterial burdens were quantified by quantitative polymerase chain reaction. OspC mutant bacteria were quantified using primers to the kanamycin resistance cassette, and wild-type bacteria were quantified using primers to the recA gene. Each time point represents blood collected from the same cohort of mice. The percent of the cohort of mice with detectible levels of bacteria in the blood at each time point are plotted over the time course. The number of mice with detectible wild type or ospC mutant bacteria burdens was significantly different at 30 min post inoculation by Fisher's exact test, * = p value < .05 strain B31-A3 and B. garinii was observed in the membrane fraction (Figure 2c ).
Borrelia genomes were quantified in the blood of mice 1 hr post inoculation and showed that production of OspC from B. burgdorferi strain B31-A3 or N40 D10/E9 by B31-A3ΔospC restored bacterial burdens to WT levels ( Figure 2a OspC is required for the establishment of mammalian infection (Tilly et al., 2006) . Consistent with published results (Tilly et al., 2006) , upon quantitation of bacterial loads by qPCR (see Materials and Methods),
we found that bacterial burdens in the blood of mice intradermally inoculated with B31-A3ΔospC were significantly lower than WT at both 3 and 7 days post inoculation ( Figure 3a) . To test whether the B. burgdorferi and B. garinii ospC alleles, which promoted bloodstream survival at 1 hr post intravenous inoculation, also promote bacteremia at these later time points, we generated strains in B31-A3ΔospC that express ospC alleles from B. burgdorferi strain B31-A3, N40 D10/E9, or B. garinii strain PBr, from the native ospC promoter (Table S1 ). Flow cytometry was performed on the strains used in these studies to confirm the surface production of OspC proteins produced under the control of the native ospC promoter (Figure 3b ,c).
We (Table S3) . One of the most abundant proteins detected in the band (per spectral counts) was the β-chain of complement component C4b (which is approximately 75 kDa) identified with 32% sequence coverage (Table S3, Figure   S2 ). Peptides of the β-chain of C4b are shared with the full length pro-protein, C4, as well as several smaller cleavage products generated during C4 processing.
To confirm a direct interaction between OspC B31 and C4b, an enzyme-linked immunosorbent assay (ELISA) was performed by incubating increasing concentrations of recombinant GST-tagged OspC B31 , OspD B31 , and GST (negative control) in C4b coated wells ( Figure S3 ).
The K D of the OspC B31 -C4b interaction was approximately 414 nM (Table 1 , Figure S3 ), an affinity consistent with a potentially biologically relevant interaction given that C4, the pro-protein from which C4b is produced during proteolytic processing, is present in blood at roughly 500 nM. No binding was detected between OspD B31 and C4b
(Table 1, Figure S3 ). The interaction between OspC B31 and C4b detected in these assays can mediate interactions between intact bacteria and C4b, because radiolabelled B. burgdorferi strain B31-A3 and B31-A3ΔospC producing OspC from strain B31-A3 bound significantly better than B31-A3ΔospC to C4b coated wells compared to bovine serum albumin (BSA; control; Figure 4b ). 
| C2 competes with C4b for binding to OspC
Complement factor C2 is a native binding partner of C4b, and this interaction is required for initiation of the subsequent steps of the complement cascade ( Figure S1 ). A plausible hypothesis is that binding binding of OspC to C4b with as low as 75 ng/ml, whereas BSA had no effect (Figure 6a ).
To determine if complement C2 could also block binding of C4b to
OspC localised on the spirochetal surface, we assayed the ability of radiolabelled B. burgdorferi strain B31-A3, B31-A3ΔospC, or B31-A3ΔospC with OspC production restored (Table S1) Table S1 ). The competitive inhibition of the C2-C4b complex formation by OspC on the surface of B. burgdorferi was also observed by immunofluorescence (IF) microscopy ( Figure S4 ). Note. n.b = no binding; OspC = outer surface protein C; OspD = outer surface protein D; SD = standard deviation.
FIGURE 5 OspC inhibits the classical and lectin complement pathways. Plates were coated with IgM (a), mannan (b), or LPS (c) and incubated with pooled human serum combined with various concentrations of GST-OspC or GST. GST-OspC significantly inhibits the deposition of complement initiated by the classical and lectin pathways compared to GST. Complement deposition in each well was determined by ELISA for complement component C3b. Data are presented as mean percent of total (complement deposition in coated wells incubated in serum only) ± standard deviation. * = Statistically significant difference between GST-OspC and GST at a particular concentration, p < .05
The binding of OspC to C4b is inhibited by exogenous C2. Figure S3 ).
| DISCUSSION
OspC has been shown to be important in the early stages of mouse infection but is detrimental to the bacteria if produced later during mammalian infection, though this early requirement has never been mechanistically defined (Skare, Shaw, Trzeciakowski, & Hyde, 2016; Tilly et al., 2006) . Using an in vivo model for the early stages of infection, we can eliminate the selection bottleneck at the site of inoculation in the skin and inject virulent or avirulent derivatives of B. burgdorferi directly into the bloodstream and monitor their ability to survive in the blood up to 1 hr post inoculation. By intravenously, inoculating a mouse strain commonly used in the Borrelia field, C3H/HeN, with B. burgdorferi strain B31-A3 deficient in OspC production, we were able to observe a role for OspC in bloodstream survival of B. burgdorferi (Caine & Coburn, 2015) . In C3H/HeN mice, we were unable to detect B31-A3ΔospC in the bloodstream in a majority of the mice, 1 hr post inoculation (Figures 1 and 2 ; Caine & Coburn, 2015) . We previously observed a gain of survival in the bloodstream when inoculating with non-infectious B. burgdorferi strain B31A exogenously expressing BBK32 from B. burgdorferi strain B31-A3 (Caine & Coburn, 2015) .
These results may indicate an importance of OspC (as presented here) and BBK32 in bloodstream survival and support in vitro findings that BBK32 binds complement component C1r (Garcia et al., 2016) . to be produced in the mouse throughout the duration of infection (Bykowski et al., 2007) . To date, only one Borrelia protein, BBK32, has been found to interact with a protein in the classical complement pathway (Garcia et al., 2016) . However, it has recently been shown that the presence of OspC on the surface of B. burgdorferi decreases uptake by professional phagocytes in vivo (Carrasco et al., 2015) .
Opsonisation of the pathogen surface can induce activation of the classical complement cascade and increases phagocytosis, though a correlation between these two processes was not made in the mentioned experiments earlier (Carrasco et al., 2015) . By using our model of short term Borrelia infection of mice, we showed that OspC from From the time course assay performed, we found the OspC deficient mutant had decreased bloodstream survival at 30 min post inoculation with significantly fewer mice with detectible ospC mutant compared to WT bacteria at this time point. Our data suggest that the ospC mutant is being cleared by a rapid innate immune mechanism, such as the complement cascade. These data corroborate the previous findings describing an ability for mice to clear the ospC mutant from the tissues despite a lack of functioning T and B cells as well as natural killer cells (Carrasco et al., 2015; Grimm et al., 2004 
| Bacteria culture and strains
All strains used in this study are described in Table S1 . B. burgdorferi strains were grown in Barbour-Stoenner-Kelly (BSKII) medium (Barbour, 1984) at 33°C to a density of 1 × 10 8 spirochetes/ml. When antibiotic selection was required, kanamycin was used at 200 μg/ml and gentamicin was used at 40 μg/ml. Presence of genomic plasmids and shuttle vectors was determined in each culture by PCR prior to inoculation into mice (Bunikis, Kutschan-Bunikis, Bonde, & Bergström, 2011; Elias et al., 2002) . All vectors were sequenced through the promoter-ospC region to ensure that no mutations had occurred.
Escherichia coli strains (Table S1) were grown in Luria-Burtani broth (Thermo Fisher Scientific, Carlsbad, CA) for cloning experiments, and 2× YT (BD Biosciences, San Jose, CA) for recombinant protein production. When antibiotic selection was required, kanamycin was used at 50 μg/ml and spectinomycin and ampicillin were used at 100 μg/ ml. Protein production was induced in BL21(DE3) strains (Table S1) with 1 mM final isopropyl β-D-1 thiogalactopyranoside (Gold BioTechnology, Inc., St. Louis, MO). All clones were verified to have the correct sequence before use.
| Borrelia strain construction
To generate B. burgdorferi strains constitutively expressing ospC alleles, plasmid pTM61spc-MCS was generated by annealing oMCS3 and oMCS4 (Table S4 ) and ligating the fragment into pGEM™-T Easy (Promega corp., Madison, WI). The MCS was excised from pGEM™-T Easy (Promega corp., Madison, WI) using BspHI and EarI, and ligated into pTM61spc (Kumar et al., 2015) at the BspHI site. The ospC deficient B. burgdorferi strain B31-A3ΔospC, generated previously (Tilly et al., 2006) , was engineered to express ospC alleles from various strains and species of Lyme disease Borrelia constitutively from the flagellar promoter (flaB), or from the ospC promoter from B. burgdorferi strain B31-A3, in the shuttle vector, pBSV2G (Table S1 ; Elias et al., 2003) . To generate ospC alleles constitutively expressed under control of the flaB promoter, alleles containing the native ribosome binding sites were amplified from genomic DNA isolated from B. burgdorferi strain B31-A3 and N40 clone D10/E9 and B. garinii strain PBr using the Wizard SV Genomic DNA Purification System (Promega corp., Madison, WI), and the oligonucleotides described in Table S4 . PCR fragments containing the ospC alleles were cloned in pGEM™-T Easy (Chen et al., 2008) and plating into semi-solid agar as previously described (Samuels, 1995) . All ospC alleles were found to have the correct sequence when carried on pBSV2G in B. burgdorferi with the exception of the ospC allele from B. burgdorferi strain N40
clone D10/E9 that was found to encode the single amino acid mutation at N53S (Shih & Chao, 2002) . The constitutively expressed WT ospC sequence from N40-D10/E9 was not successfully maintained in B. burgdorferi B31-A3ospC despite multiple independent rounds of cloning and transformation.
To generate the plasmids encoding ospC alleles under control of the native promoter, the ospC genes from B. burgdorferi strain B31-A3 and N40 clone D10/E9, and B. garinii strain PBr were PCR amplified with oligonucleotides containing a SalI site at the 5′ end and a BamHI site at the 3′ end (Table S4) . Amplified DNA fragments were inserted into the TA cloning vector pCR2.1-TOPO (Invitrogen, Houston, TX)
to generate plasmids pCR2.1-ospC B31 , pCR2.1-ospC N40-D10/E9 or pCR2.1-ospC PBr . The plasmids were then digested with SalI and BamHI to release the ospC alleles, and cloned into the SalI and BamHI sites of pBBE22. The promoter region of ospC from B. burgdorferi strain B31-A3, beginning 184 BP upstream from the start codon of ospC (Fischer, LeBlanc, & Leong, 2006) , was PCR amplified adding HindIII and SalI sites at the 5′ and 3′ ends, respectively, using primers pospCfp and pospCrp (Table S4) . Promoter fragments were then inserted into the HindIII and SalI sites of pBBE22 to drive the expression of ospC B31 , ospC N40-D10/E9 , and ospC PBr .
| Confirmation of OspC surface production on B. burgdorferi
To confirm the production of OspC classes on the surface of B. burgdorferi, cultures were grown to a density of >1 × 10 8 /mL in BSKII. Cells were pelleted (644 × g, 30 min, at ambient temperature), supernatants were pipetted off, and pellets were resuspended in 1 ml of sterile 1× PBS. Cells were centrifuged at 5,900 × g for 8 min at ambient temperature, and supernatants were pipetted off. Bacteria were resuspended in 1 ml of sterile 1× PBS and diluted to 1 × 10 8 /ml in 1 ml final volume with or without 10 μg/ml proteinase K (Sigma- For verification of surface production of OspC from B. garinii, which is not detected by the antibody used for immunoblotting, membranes were extracted from cultures using Triton X-114 and analysed by silver stain (Brandt, Riley, Radolf, & Norgard, 1990) . Briefly, Borrelia cultures grown in BSKII and collected at a density > 1 × 10 8 /ml. 1 × 10 9 total bacteria were centrifuged at 1145 × g, 30 min at 4°C. Bacterial pellets were washed in room temperature 1× PBS + 0.2% BSA and centrifuged at 9,300 × g for 10 min at ambient temperature. Cells were resuspended in 1 ml 1× PBS + 2% Triton X-114 (Sigma-Aldrich, St.
Louis, MO) and incubated overnight at 4°C. Lysates were centrifuged at 16,100 × g, 30 min at 4°C, and supernatants were warmed to 37°C.
Warmed supernatants were centrifuged 16,100 × g, 15 min at ambient temperature to separate membrane from non-membrane fractions.
Both fractions were washed in cold 1× PBS, proteins were precipitated with 95% ethanol and analysed by 15% SDS-PAGE and silver stain (Shevchenko, Wilm, Vorm, & Mann, 1996) . 
| Mouse infections
Short term intravenous inoculation and perfusion experiments were performed as previously described (Caine & Coburn, 2015) . Briefly, C3H/HeN mice under anaesthesia were retro-orbitally inoculated with 1 × 10 8 B. burgdorferi. Bacteria were allowed to circulate for 1 hr, and blood was collected by cardiac puncture. Animals were perfused with sterile saline to wash away any unbound bacteria from the vasculature.
Tissues were harvested, rinsed, and frozen on dry ice before genomic DNA isolation and quantitation of Borrelia and mouse genomes by qPCR as previously described (Table S3 ; Caine & Coburn, 2015; Liveris et al., 2002) .
Time course experiments were performed as described above except that at 5, 10, 20, 30, and 60 min post inoculation blood was collected from the saphenous vein of each animal. Prior to the first time point, mice were anaesthetised, and hair was removed with a hair clipper, skin was sterilised with 70% ethanol, and a small amount of petroleum jelly was applied to each leg. The saphenous vein was punctured with a 23-gauge needle, and a maximum of 100 μl of blood was collected at each time point using a sterile pipet and combined with citrate anticoagulant (detailed above) to a 10% final volume and stored on dry ice. The skin of each leg was re-sterilised with 70% ethanol, and a new layer of petroleum jelly was applied prior to each time point.
Blood collection from the saphenous vein alternated between the left and right leg with each time point. Blood samples were stored at -80°C until DNA was isolated. OspC mutant bacteria were quantified by qPCR using primers that amplified a section of the kanamycin resistance cassette with a detection limit of 61 copies, and WT bacteria were quantified using recA primers with a detection limit of 6.1 gene copies as previously described (Caine & Coburn, 2015; Liveris et al., 2002) .
In long term experiments, 4-week-old female C3H/HeN mice (Charles River, Wilmington, MA) were used. Mice were infected by intradermal injection as previously described (Weening et al., 2008) with 1 × 10 4 B. burgdorferi. To test the bloodstream survival promoted by OspC variants, mice were euthanized at 3 or 7 days post inoculation, blood was collected, and genomic DNA was extracted for quantification of bacterial and mammalian genomes by qPCR (Table S4; Caine & Coburn, 2015; Liveris et al., 2002; Ristow et al., 2012) .
4.7 | Generation of recombinant GST proteins and antisera.
To generate recombinant GST-tagged OspC proteins, the ospC open reading frames lacking the putative signal sequences from B. burgdorferi strains B31-A3 and N40 clone D10/E9, and B. garinii strain PBr were amplified and cloned in pGEX4T2 (GE Healthcare, Piscataway, NJ) as previously described (Benoit, Fischer, Lin, Parveen, & Leong, 2011 ; Table S4 ). Amplified fragments were engineered to encode a BamHI site at the 5′ end and a stop codon followed by a SalI site at the 3′ end. PCR products were sequentially digested with BamHI and SalI and then inserted into the BamHI and SalI sites of pGEX4T2 (GE Healthcare, Piscataway, NJ). The resulting plasmids were transformed into E. coli strain BL21 (DE3 ; Table S1 ) and induced for production of GST-tagged OspC variants. Proteins were purified by glutathione chromatography according to the manufacturer's instructions (BD Biosciences, San Jose, CA). Antisera against OspC B31-A3 , OspC N40-D10/E9 , and OspC PBr were generated by immunising 5-week-old BALB/C mice with each of the OspC proteins as described previously (Barthold, Hodzic, Tunev, & Feng, 2006) .
| Glutathione-S-transferase (GST) fusion protein pull down assays
A total of 10 μg of GST tagged OspC B31 or OspD B31 (negative control),
purified from E. coli, was incubated with a 50% slurry of glutathione agarose beads for 1 hr at 4°C (BD Bioscience, Franklin Lake, NJ) and centrifuged at 13,000 × g, 1 min at 4°C, and supernatants were 96-well microtiter plates were coated with 100 μl containing 1 μg C4b purified from human serum, or with BSA (negative control) similar to previously described methods (Fischer et al., 2006) . GST-OspC
(1 μM) from B. burgdorferi strain B31-A3 was combined with 300, 150, 75, or 37.5 ng/ml of soluble C2 purified from normal human serum (#A112, Complement Technology, Inc., Tyler, TX) or BSA (negative control) and incubated at room temperature for 1 hr prior to addition to C4b-coated wells. Binding of GST-OspC was measured by ELISA as described above.
4.11 | Binding of radiolabelled B. burgdorferi to purified C4b
Binding of B. burgdorferi to purified C4b was determined in a similar way to a previously described protocol (Benoit et al., 2011) with the following modifications. Briefly, spirochetes were radiolabelled with The percent bacteria bound was determined by dividing the radioactive counts in the experimental wells by the counts in the inoculum.
Four experiments were performed in triplicate.
| Inhibition of binding of spirochetes to C4b by exogenous C2
Spirochetes were prepared as described above and incubated for 30 min at room temperature in BSK-H supplemented with 1 μg of purified C2 (#A112, Complement Technology, Inc., Tyler, TX) or BSA (negative control). After incubation, spirochetes were diluted 1:3 in Glucose hepes saline (GHS) buffer (10 mM glucose, 10 mM Hepes, and 50 mM NaCl at pH 7.0) before incubating with C4b coated wells.
The percent of bound bacteria was calculated as described above.
| Complement inhibition ELISAs
Complement inhibition assays were performed as previously described (Garcia et al., 2016) 
| Immunofluorescence (IF) microscopy
Human complement complexes from pooled human serum deposited on the surface of B. burgdorferi were detected by IF microscopy. WT or ospC mutant B. burgdorferi were grown in serum-free BSKII ( (Posey & Gherardini, 2000) , without the addition of 3-phosphoglyceric acid) and used at densities >1 × 10 8 /ml. Cultures were incubated on fibro- Fluorescence microscopy images were acquired by a Nikon Eclipse 
